Sign in

CIK 0001822791

  • Non-accelerated filer
  • Smaller reporting company
Ticker
CLNN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
852828339
Phone
+1 801-676-9695
Business address
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY, UT, 84121
Former names
Chelsea Worldwide Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-05-16 Glanzman Robert Chief Medical Officer Sale −4,717 $2.03 $10K 10,564
2022-02-15 Glanzman Robert Chief Medical Officer Grant or award · Stock Options (Right to buy) +140,000 140,000
2021-11-04 Glanzman Robert Chief Medical Officer Grant or award · Stock Options (Right to buy) +100,000 100,000
2021-06-30 Glanzman Robert Chief Medical Officer Grant or award +15,281 15,281
2021-04-30 Glanzman Robert Chief Medical Officer Grant or award · Stock Options (Right to buy) +95,000 95,000

Page 1 of 1 · 5 trades